MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honkakoski, P.
Right arrow Articles by Negishi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honkakoski, P.
Right arrow Articles by Negishi, M.

Vol. 53, Issue 4, 597-601, April 1998

ACCELERATED COMMUNICATION
Activation by Diverse Xenochemicals of the 51-Base Pair Phenobarbital-Responsive Enhancer Module in the CYP2B10 Gene

Paavo Honkakoski,1 Rick Moore, Kimberly A. Washburn, and Masahiko Negishi

Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709

By extending previous studies of the phenobarbital (PB)-responsive 132-base pair (bp) enhancer sequence in the CYP2B10 gene, we have delimited a 51-bp enhancer element that is fully inducible by PB in mouse primary hepatocytes. Sixteen structurally unrelated phenobarbital-type inducers activated the 51-bp enhancer element in transient transfection assays. The results thus indicate that most PB-type inducers, if not all inducers, increase the transcription of the CYP2B10 gene by activating this 51-bp element, now designated PB-responsive enhancer module or PBREM.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. Surapureddi, R. Rana, J. K. Reddy, and J. A. Goldstein
Nuclear Receptor Coactivator 6 Mediates the Synergistic Activation of Human Cytochrome P-450 2C9 by the Constitutive Androstane Receptor and Hepatic Nuclear Factor-4{alpha}
Mol. Pharmacol., September 1, 2008; 74(3): 913 - 923.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. J. Johnson, A. Owen, N. Plant, P. G. Bray, and S. A. Ward
Drug-Regulated Expression of Plasmodium falciparum P-Glycoprotein Homologue 1: a Putative Role for Nuclear Receptors
Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1438 - 1445.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Y. Yamazaki, S. Kakizaki, N. Horiguchi, N. Sohara, K. Sato, H. Takagi, M. Mori, and M. Negishi
The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis
Gut, April 1, 2007; 56(4): 565 - 574.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Sakai, H. Iwata, E.-Y. Kim, O. Tsydenova, N. Miyazaki, E. A. Petrov, V. B. Batoev, and S. Tanabe
Constitutive Androstane Receptor (CAR) as a Potential Sensing Biomarker of Persistent Organic Pollutants (POPs) in Aquatic Mammal: Molecular Characterization, Expression Level, and Ligand Profiling in Baikal Seal (Pusa sibirica)
Toxicol. Sci., November 1, 2006; 94(1): 57 - 70.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Tsutsui, S. Ogawa, Y. Inada, E. Tomioka, A. Kamiyoshi, S. Tanaka, T. Kishida, M. Nishiyama, M. Murakami, J. Kuroda, et al.
CHARACTERIZATION OF CYTOCHROME P450 EXPRESSION IN MURINE EMBRYONIC STEM CELL-DERIVED HEPATIC TISSUE SYSTEM
Drug Metab. Dispos., April 1, 2006; 34(4): 696 - 701.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Lempiainen, F. Molnar, M. Macias Gonzalez, M. Perakyla, and C. Carlberg
Antagonist- and Inverse Agonist-Driven Interactions of the Vitamin D Receptor and the Constitutive Androstane Receptor with Corepressor Protein
Mol. Endocrinol., September 1, 2005; 19(9): 2258 - 2272.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Swales, S. Kakizaki, Y. Yamamoto, K. Inoue, K. Kobayashi, and M. Negishi
Novel CAR-mediated Mechanism for Synergistic Activation of Two Distinct Elements within the Human Cytochrome P450 2B6 Gene in HepG2 Cells
J. Biol. Chem., February 4, 2005; 280(5): 3458 - 3466.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto
Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes
Mol. Cell. Biol., September 15, 2004; 24(18): 7931 - 7940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Frank, F. Molnar, M. Matilainen, H. Lempiainen, and C. Carlberg
Agonist-dependent and Agonist-independent Transactivations of the Human Constitutive Androstane Receptor Are Modulated by Specific Amino Acid Pairs
J. Biol. Chem., August 6, 2004; 279(32): 33558 - 33566.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Swales and M. Negishi
CAR, Driving into the Future
Mol. Endocrinol., July 1, 2004; 18(7): 1589 - 1598.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Podvinec, C. Handschin, R. Looser, and U. A. Meyer
Identification of the xenosensors regulating human 5-aminolevulinate synthase
PNAS, June 15, 2004; 101(24): 9127 - 9132.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. Jackson, S. S. Ferguson, R. Moore, M. Negishi, and J. A. Goldstein
The Constitutive Active/Androstane Receptor Regulates Phenytoin Induction of Cyp2c29
Mol. Pharmacol., June 1, 2004; 65(6): 1397 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. R. Faucette, H. Wang, G. A. Hamilton, S. L. Jolley, D. Gilbert, C. Lindley, B. Yan, M. Negishi, and E. L. LeCluyse
REGULATION OF CYP2B6 IN PRIMARY HUMAN HEPATOCYTES BY PROTOTYPICAL INDUCERS
Drug Metab. Dispos., March 1, 2004; 32(3): 348 - 358.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. J. Cherrington, A. L. Slitt, J. M. Maher, X.-X. Zhang, J. Zhang, W. Huang, Y.-J. Y. Wan, D. D. Moore, and C. D. Klaassen
INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
Drug Metab. Dispos., November 1, 2003; 31(11): 1315 - 1319.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Frank, M. M. Gonzalez, C. Oinonen, T. W. Dunlop, and C. Carlberg
Characterization of DNA Complexes Formed by the Nuclear Receptor Constitutive Androstane Receptor
J. Biol. Chem., October 31, 2003; 278(44): 43299 - 43310.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Wyde, E. Bartolucci, A. Ueda, H. Zhang, B. Yan, M. Negishi, and L. You
The Environmental Pollutant 1,1-Dichloro-2,2-bis (p-chlorophenyl)ethylene Induces Rat Hepatic Cytochrome P450 2B and 3A Expression through the Constitutive Androstane Receptor and Pregnane X Receptor
Mol. Pharmacol., August 1, 2003; 64(2): 474 - 481.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. M. Ledda-Columbano, M. Pibiri, D. Concas, F. Molotzu, G. Simbula, C. Cossu, and A. Columbano
Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP
Carcinogenesis, June 1, 2003; 24(6): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. A. Kliewer, B. Goodwin, and T. M. Willson
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Endocr. Rev., October 1, 2002; 23(5): 687 - 702.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. Xiao, X. Cui, V. Madison, R. E. White, and K.-C. Cheng
Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
Drug Metab. Dispos., September 1, 2002; 30(9): 951 - 956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. S. Ferguson, E. L. LeCluyse, M. Negishi, and J. A. Goldstein
Regulation of Human CYP2C9 by the Constitutive Androstane Receptor: Discovery of a New Distal Binding Site
Mol. Pharmacol., September 1, 2002; 62(3): 737 - 746.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. S. Craft, M. J. DeVito, and K. M. Crofton
Comparative Responsiveness of Hypothyroxinemia and Hepatic Enzyme Induction in Long-Evans Rats Versus C57BL/6J Mice Exposed to TCDD-like and Phenobarbital-like Polychlorinated Biphenyl Congeners
Toxicol. Sci., August 1, 2002; 68(2): 372 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Min, J. K. Kemper, and B. Kemper
Glucocorticoid Receptor-interacting Protein 1 Mediates Ligand-independent Nuclear Translocation and Activation of Constitutive Androstane Receptor in Vivo
J. Biol. Chem., July 12, 2002; 277(29): 26356 - 26363.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Ueda, S. Kakizaki, M. Negishi, and T. Sueyoshi
Residue Threonine 350 Confers Steroid Hormone Responsiveness to the Mouse Nuclear Orphan Receptor CAR
Mol. Pharmacol., June 1, 2002; 61(6): 1284 - 1288.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kakizaki, S. Karami, and M. Negishi
Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of the Cyp2b10 Gene in Mouse Primary Hepatocytes
Drug Metab. Dispos., February 1, 2002; 30(2): 208 - 211.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Ueda, H. K. Hamadeh, H. K. Webb, Y. Yamamoto, T. Sueyoshi, C. A. Afshari, J. M. Lehmann, and M. Negishi
Diverse Roles of the Nuclear Orphan Receptor CAR in Regulating Hepatic Genes in Response to Phenobarbital
Mol. Pharmacol., January 1, 2002; 61(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Handschin, M. Podvinec, J. Stockli, K. Hoffmann, and U. A. Meyer
Conservation of Signaling Pathways of Xenobiotic-Sensing Orphan Nuclear Receptors, Chicken Xenobiotic Receptor, Constitutive Androstane Receptor, and Pregnane X Receptor, from Birds to Humans
Mol. Endocrinol., September 1, 2001; 15(9): 1571 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Zelko, T. Sueyoshi, T. Kawamoto, R. Moore, and M. Negishi
The Peptide Near the C Terminus Regulates Receptor CAR Nuclear Translocation Induced by Xenochemicals in Mouse Liver
Mol. Cell. Biol., April 15, 2001; 21(8): 2838 - 2846.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. Yoshinari, T. Sueyoshi, R. Moore, and M. Negishi
Nuclear Receptor CAR as a Regulatory Factor for the Sexually Dimorphic Induction of CYP2B1 Gene by Phenobarbital in Rat Livers
Mol. Pharmacol., February 1, 2001; 59(2): 278 - 284.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
W. Xie, J. L. Barwick, C. M. Simon, A. M. Pierce, S. Safe, B. Blumberg, P. S. Guzelian, and R. M. Evans
Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Genes & Dev., December 1, 2000; 14(23): 3014 - 3023.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
T. Kawamoto, S. Kakizaki, K. Yoshinari, and M. Negishi
Estrogen Activation of the Nuclear Orphan Receptor CAR (Constitutive Active Receptor) in Induction of the Mouse Cyp2b10 Gene
Mol. Endocrinol., November 1, 2000; 14(11): 1897 - 1905.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Handschin and U. A. Meyer
A Conserved Nuclear Receptor Consensus Sequence (DR-4) Mediates Transcriptional Activation of the Chicken CYP2H1 Gene by Phenobarbital in a Hepatoma Cell Line
J. Biol. Chem., April 28, 2000; 275(18): 13362 - 13369.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Kim, I. Rivera-Rivera, and B. Kemper
Tissue-specific chromatin structure of the phenobarbital- responsive unit and proximal promoter of CYP2B1/2 and modulation by phenobarbital
Nucleic Acids Res., March 1, 2000; 28(5): 1126 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
U. Savas, K. J. Griffin, and E. F. Johnson
MINIREVIEW: Molecular Mechanisms of Cytochrome P-450 Induction by Xenobiotics: An Expanded Role for Nuclear Hormone Receptors
Mol. Pharmacol., November 1, 1999; 56(5): 851 - 857.
[Full Text]


Home page
Mol. Cell. Biol.Home page
T. Kawamoto, T. Sueyoshi, I. Zelko, R. Moore, K. Washburn, and M. Negishi
Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene
Mol. Cell. Biol., September 1, 1999; 19(9): 6318 - 6322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Skarin, R. Becher, A. Bucht, K. Duvefelt, S. Bohm, T. Ranneberg-Nilsen, E. M. Lilleaas, P. E. Schwarze, and R. Toftgård
Cis-Acting Sequences from the Rat Cytochrome P450 2B1 Gene Confer Pulmonary and Phenobarbital-Inducible Expression in Transgenic Mice
Am. J. Respir. Cell Mol. Biol., August 1, 1999; 21(2): 177 - 184.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Sueyoshi, T. Kawamoto, I. Zelko, P. Honkakoski, and M. Negishi
The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
J. Biol. Chem., March 5, 1999; 274(10): 6043 - 6046.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. Dogra, B. P. Davidson, and B. K. May
Analysis of a Phenobarbital-Responsive Enhancer Sequence Located in the 5' Flanking Region of the Chicken CYP2H1 Gene: Identification and Characterization of Functional Protein-Binding Sites
Mol. Pharmacol., January 1, 1999; 55(1): 14 - 22.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
E. T. Morgan, M. B. Sewer, H. Iber, F. J. Gonzalez, Y.-H. Lee, R. H. Tukey, S. Okino, T. Vu, Y.-H. Chen, J. S. Sidhu, et al.
Physiological and Pathophysiological Regulation of Cytochrome P450
Drug Metab. Dispos., December 1, 1998; 26(12): 1232 - 1240.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
P. Honkakoski, I. Zelko, T. Sueyoshi, and M. Negishi
The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene
Mol. Cell. Biol., October 1, 1998; 18(10): 5652 - 5658.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Paquet, E. Trottier, M.-J. Beaudet, and A. Anderson
Mutational Analysis of the CYP2B2 Phenobarbital Response Unit and Inhibitory Effect of the Constitutive Androstane Receptor on Phenobarbital Responsiveness
J. Biol. Chem., December 1, 2000; 275(49): 38427 - 38436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R. Kast, B. Goodwin, P. T. Tarr, S. A. Jones, A. M. Anisfeld, C. M. Stoltz, P. Tontonoz, S. Kliewer, T. M. Willson, and P. A. Edwards
Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor
J. Biol. Chem., January 18, 2002; 277(4): 2908 - 2915.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics